1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A lower eGFRcystatin C/eGFRcreatinine ratio is associated with greater cardiovascular risk (higher Framingham Risk Score) in Chinese patients with newly diagnosed type 2 diabetes mellitus
(
- Contribution to journal › Article
- 2022
-
Mark
Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort
(
- Contribution to journal › Article
- 2021
-
Mark
Glomerular filtration and shrunken pore syndrome in children and adults
(
- Contribution to journal › Article
-
Mark
The cardiorenal syndrome: Structural and functional aspects including associations with the shrunken pore syndrome
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Identification of the high risk hip fracture patients
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins
(
- Contribution to journal › Article
-
Mark
The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFR
cystatin C
/eGFR
creatinine
-ratio
(
- Contribution to journal › Article
-
Mark
eGFR, cystatin C and creatinine in shrunken pore syndrome
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Cystatin C as a Multifaceted Biomarker in Kidney Disease and Its Role in Defining "Shrunken Pore Syndrome"
2017) p.225-240(
- Chapter in Book/Report/Conference proceeding › Book chapter